BRAIN Health Image with BRAIN Waves for BRAINWeek

Traditional brain health education often overlooks the vital link between mental and physical well-being, leading to suboptimal patient outcomes.

Welcome to Your Brain Health Education Hub

BRAIN Waves taps into decades of medical education expertise to curate innovative brain health education, offering the latest insights, news, and clinical approaches in easily digestible formats. Our brain health education resources and partner offerings translate cutting-edge research into practical clinical strategies.

Explore our brain education resources and enhance your clinical expertise to better treat brain-related conditions while fostering a deeper understanding of holistic brain health. Your journey to clinical excellence starts here.

Stay up to date with the latest information on live events, online educational offerings, and industry news by subscribing to the BRAINWaves newsletter powered by BRAINWeek, a resource hub of brain health education to equip you to foster holistic brain health.

Explore Our Partner Learning Activities

Brain Health Summit
Addressing The 4 M’s of Brain Aging

Brain Health Summit – Addressing The 4 M’s of Brain Aging

Clinical research has demonstrated that aging is not a uniform process and certain aspects of the nervous system have age-related vulnerabilities which cause the problems that are responsible for failures of the 4M’s of brain health:

Pathophysiology of Alzheimer's Disease

Pathophysiology of Alzheimer's Disease

Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies:

Differential Diagnosis of Memory Loss & Dementia

In this lecture the broad differential diagnosis of memory loss and dementia are presented, including dementia with Lewy bodies, vascular dementia, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, normal pressure hydrocephalus, Creutzfeldt-Jakob disease, depression, Lyme disease, chronic traumatic encephalopathy, and others.  

BRAINWeek Bites - Bringing the latest in brain health and wellness innovation.

News & Blogs

How to Master Early Alzheimer’s Detection for Improved Patient Outcomes 

Alzheimer’s Disease: Rising Cases, Lagging Diagnoses, and Undertreatment Currently, about 6.2 million Americans aged 65 and older grapple with Alzheimer’s dementia (AD), a figure set to balloon to 13.8 million by 2060, barring medical breakthroughs to prevent, slow, or cure AD. In 2011, approximately 4.5 million individuals aged sixty-five and above were living with clinical Alzheimer’s disease.

Read More »

Understanding and Managing Migraines: A Comprehensive Overview 

Migraine Prevalence, Costs, and Treatment Gaps Migraines are not just a nuisance; they also pose a significant public health challenge, affecting up to 17% of women and 6% of men annually. These statistics vary globally, with North America experiencing the highest prevalence, followed by South America, Central America, Europe, Asia, and Africa. Shockingly, migraines account for

Read More »

Realizing Health Equity: Four Key Areas in Brain Health  

As we approach World Health Day on April 7, 2024, under the theme ‘My Health, My Right,’ it’s imperative to recognize the universal right to quality healthcare, education, and information. Brain health is central to this notion – the cornerstone of an individual’s capacity to realize their full potential over life course. As a dedicated provider, it’s

Read More »

FDA Grants Breakthrough Status to Cybin’s CYB003 for Major Depressive Disorder

Cybin, a clinical-stage biopharmaceutical company, has received FDA Breakthrough Therapy Designation (BTD) for CYB003, a novel deuterated psilocybin analog designed to treat Major Depressive Disorder (MDD). This designation acknowledges CYB003’s potential to revolutionize depression treatment, addressing a significant unmet need affecting millions globally. In a phase 2 trial, CYB003 demonstrated positive topline results: Patients receiving

Read More »

Explore Our Partner Blogs

A4M: Redefining Medicine
Special Guest Rhonda Patrick, PhD

A4M: Redefining Medicine
Special Guest Scott Fisher, MD

Digital Sponsorship Opportunities Available

Robert McCarry

Director, Business Development


Share this event with your community: